Joshua Silverman

Joshua Silverman

Chief Executive Officer chez PHARMACYTE BIOTECH, INC.

Fortune : 237 076 $ au 31/03/2024

53 ans
Health Technology
Finance
Consumer Services

Profil

Joshua Nathaniel Silverman founded Iroquois Capital LP in 2002, where he is working as Chief Executive Officer from 2002, Iroquois Capital Management LLC in 2003, where he worked as Co-Chief Investment Officer & Managing Member from 2003 to 2016, and Parkfield Funding LLC in 2016, where he is working as Managing Member from 2016.
Mr. Silverman also currently works at PharmaCyte Biotech, Inc., as Chairman, President & Chief Executive Officer from 2022, Neurotrope, Inc., as Chairman from 2016, Synaptogenix, Inc., as Independent Chairman from 2016, Petros Pharmaceuticals, Inc., as Vice Chairman from 2020, AYRO, Inc., as Executive Chairman, Chief Financial Officer & CAO from 2024, MyMD Pharmaceuticals, Inc., as Chairman, Femasys, Inc., as Independent Director from 2023, Crellin Capital LLC, as Director, and Taplmmune, Inc., as Director.
Mr. Silverman also formerly worked at DropCar, Inc., as Chairman, MIRA Pharmaceuticals, Inc., as Chairman, Alanco Technologies, Inc., as Director in 2016, National Holdings Corp., as Independent Director from 2014 to 2016, WPCS International, Inc., as Director, Marker Therapeutics, Inc., as Independent Director from 2016 to 2018, Akers Biosciences, Inc., as Lead Independent Director from 2018 to 2020, MGT Capital Investments, Inc., as Independent Director from 2014 to 2016, Atrinsic, Inc., as Director, Joele Frank, Wilkinson Brimmer Katcher, as Director, JNS Holdings Corp., as Director, Protagenic Therapeutics, Inc., as Independent Non-Executive Director from 2016 to 2022, and Vertical Ventures LLC, as Co-Chief Investment Officer from 2000 to 2003.
Mr. Silverman received his undergraduate degree in 1992 from Lehigh University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/03/2024 50 000 ( 0,59% ) 118 500 $ 31/03/2024
27/10/2023 49 584 ( 1,01% ) 82 805 $ 31/03/2024
26/03/2024 11 238 ( 0,51% ) 16 632 $ 31/03/2024
29/03/2024 5 000 ( 0,23% ) 11 950 $ 31/03/2024
08/04/2024 38 238 ( 0,19% ) 7 189 $ 31/03/2024

Postes actifs de Joshua Silverman

SociétésPosteDébut
NEUROTROPE, INC. Chairman 04/08/2016
AYRO, INC. Director of Finance/CFO 01/03/2024
PETROS PHARMACEUTICALS Director/Board Member 01/01/2020
SYNAPTOGENIX, INC. Chairman 04/08/2016
MYMD PHARMACEUTICALS, INC. Chairman -
PHARMACYTE BIOTECH, INC. Chief Executive Officer 06/10/2022
FEMASYS INC. Director/Board Member 21/11/2023
Founder 01/08/2016
Taplmmune, Inc. Director/Board Member -
░░░░░░░ ░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Tous les postes actifs de Joshua Silverman

Anciens postes connus de Joshua Silverman

SociétésPosteFin
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Joshua Silverman

Formation de Joshua Silverman

Lehigh University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Joshua Silverman

Relations

99

Relations au 1er degré

26

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées11
MARKER THERAPEUTICS, INC.

Health Technology

FEMASYS INC.

Electronic Technology

MGT CAPITAL INVESTMENTS, INC.

Technology Services

PHARMACYTE BIOTECH, INC.

Health Technology

JNS HOLDINGS CORPORATION

Industrial Services

SYNAPTOGENIX, INC.

Health Technology

PROTAGENIC THERAPEUTICS, INC.

Health Technology

PETROS PHARMACEUTICALS

Health Technology

AYRO, INC.

Producer Manufacturing

MYMD PHARMACEUTICALS, INC.

Health Technology

MIRA PHARMACEUTICALS, INC.

Health Technology

Entreprise privées14

Industrial Services

Finance

Consumer Services

Health Technology

Finance

Health Technology

Finance

Commercial Services

Finance

Commercial Services

Finance

Finance

Consumer Services

Taplmmune, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Joshua Silverman